ART Medical vs EarlySense
ART Medical vs EarlySense, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ART Medical is on 52/100 and EarlySense on 65/100.
Where each one leads
ART Medical
- agent readiness: 37/100 against 22/100
- headcount: 78 against 18
- headcount growth: +12.3% against -27.2%
EarlySense
- our overall score: 65/100 against 52/100
- domain rating: 38/100 against 12/100
- funding raised: $131M against $40.0M
- LinkedIn following: 10,030 against 6,403
At a glance
| Measure | ART Medical | EarlySense |
|---|---|---|
| What it is | ART Medical develops the smART+ Platform, an ecosystem of software and sensor-based tools to detect, predict, and prevent ICU-acquired complications. | EarlySense provides a continuous patient monitoring solution to enhance safety and reduce risk for general care patients. |
| Category | Healthcare, Nutrition, ICU Management, Sensor | Healthcare, Monitor, Patient, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware, Software | Hardware, Software |
| Founded | 2009 | 2004 |
| Headquarters | Tel Aviv, Israel | Ramat Gan, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | ART Medical | EarlySense |
|---|---|---|
| Employees | 78 | 18 |
| Headcount growthLast 12 months | +12.3% | -27.2% |
| Total funding | $40.0M | $131M |
| Latest round | Series B | Series F |
| Valuation | Not published | $325M |
| LinkedIn followers | 6,403 | 10,030 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ART Medical | EarlySense |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 65/100 |
| Traction | 57/100 | 53/100 |
| Team | 30/100 | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 29/100 | 30/100 |
| Quality | 58/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 12/100 | 38/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ART Medical | EarlySense |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager, Linkedin Insight | Not detected |
ART Medical vs EarlySense: common questions
Which is better, ART Medical or EarlySense?
On our 0-100 score EarlySense rates higher (65/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do ART Medical and EarlySense compare on the numbers?
ART Medical leads on agent readiness (37/100 against 22/100), headcount (78 against 18), headcount growth (+12.3% against -27.2%). EarlySense leads on our overall score (65/100 against 52/100), domain rating (38/100 against 12/100), funding raised ($131M against $40.0M), LinkedIn following (10,030 against 6,403).
Read the full ART Medical review and pricing or the EarlySense review and pricing. You can also browse other ART Medical alternatives we track.